Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rasagiline on olfactory function in patients with Parkinson's disease
2008-005085-30Phase 3Terminated
- Sponsor
- Technische Universität Dresden
- Start
- Mar 2009
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Technische Universität Dresden. Primary endpoint: SDI score change within 120 days. Started Mar 2009; status: terminated.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2008-005085-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005085-30.